We are live on ! Find out more
BIA

Biondo Investment Advisors Portfolio holdings

AUM $780M
1-Year Est. Return 21.03%
This Fund
S&P 500
This Quarter Est. Return
-1.18%
1 Year Est. Return
+21.03%
3 Year Est. Return
+89.14%
5 Year Est. Return
+116.93%
10 Year Est. Return
+716.27%
AUM
$391M
AUM Growth
-$30.5M
Cap. Flow
-$19.7M
Cap. Flow %
-5.03%
Top 10 Hldgs %
48.1%
Holding
93
New
5
Increased
41
Reduced
33
Closed
7

Top Sells

Rank Stock Value
1
MA icon
Mastercard
MA
+$7.56M
2
EXAS
Exact Sciences
EXAS
+$5.76M
3
UAA icon
Under Armour
UAA
+$5.07M
4
DORM icon
Dorman Products
DORM
+$2.13M
5
ISRG icon
Intuitive Surgical
ISRG
+$1.55M

Sector Composition

Rank Sector Weight
1 Healthcare 34.12%
2 Technology 18.35%
3 Financials 13.13%
4 Consumer Discretionary 7.6%
5 Communication Services 6.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VEEV icon
76
Veeva Systems
VEEV
$34.8B
$382K 0.1%
2,500
+500
+25% +$80.2K
SBBX
77
DELISTED
SB One Bancorp Common Stock
SBBX
$372K 0.1%
16,499
KTB icon
78
Kontoor Brands
KTB
$4.62B
$327K 0.08%
9,310
-3,052
-25% -$99K
SDS icon
79
ProShares UltraShort S&P500
SDS
$391M
$295K 0.08%
+400
New +$302K
V icon
80
Visa
V
$684B
$280K 0.07%
1,625
-25
-2% -$4.45K
MCI
81
Barings Corporate Investors
MCI
$339M
$253K 0.06%
15,000
BAC icon
82
Bank of America
BAC
$444B
$228K 0.06%
7,800
-5,000
-39% -$144K
QQQ icon
83
Invesco QQQ Trust
QQQ
$481B
$217K 0.06%
+1,150
New +$218K
MDY icon
84
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$27.2B
$206K 0.05%
+584
New +$205K
GCVRZ
85
DELISTED
Sanofi Contingent Value Rights
GCVRZ
$6K ﹤0.01%
10,800
BLUE
86
DELISTED
bluebird bio
BLUE
-131
Closed -$216K
DORM icon
87
Dorman Products
DORM
$4.15B
-24,435
Closed -$2.13M
REGN icon
88
Regeneron Pharmaceuticals
REGN
$78.8B
-1,050
Closed -$329K
UAA icon
89
Under Armour
UAA
$2.83B
-199,907
Closed -$5.07M
ULTA icon
90
Ulta Beauty
ULTA
$23.2B
-1,980
Closed -$687K
BCPC
91
Balchem Corp
BCPC
$5.72B
-2,000
Closed -$200K
SWAV
92
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
-9,250
Closed -$528K

Similar funds

Biondo Investment Advisors's Q3 2019 Portfolio in Review

As of Q3 2019, Biondo Investment Advisors held 93 positions worth $391M, down 7.2% from $422M the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Biondo Investment Advisors withdrew a net $19.7M in Q3 2019, closing 7 positions and reducing 33 holdings. Its most notable exit was Under Armour, an estimated $5.07M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, down from 37% a quarter earlier, followed by Technology and Financials.

Against the trend, Biondo Investment Advisors opened a new position in Iovance Biotherapeutics worth $3.36M.

  • Biondo Investment Advisors's largest Q3 2019 buy was Iovance Biotherapeutics: 184,835 shares worth $3.36M.
  • Biondo Investment Advisors added most to Boeing in Q3 2019, an estimated $997K increase.
  • Biondo Investment Advisors's biggest Q3 2019 reduction was Mastercard, cutting an estimated $7.56M.
  • Biondo Investment Advisors fully exited Under Armour in Q3 2019, selling an estimated $5.07M.
  • Biondo Investment Advisors's ten largest holdings make up 48% of its $391M portfolio in Q3 2019.
  • Biondo Investment Advisors opened 5 new positions and closed 7 in Q3 2019.
  • Biondo Investment Advisors's portfolio value fell 7.2% quarter-over-quarter to $391M.

Based on Biondo Investment Advisors's 13F filing for Q3 2019, filed 5 Nov 2019.